NBIX Jude Onyia sells $7.8M worth of shares
Jul 12, 2025, 4:34 AM
0.00%
What does NBIX do
Neurocrine Biosciences, based in San Diego, develops pharmaceuticals for neurological disorders and employs 1,448 people. Its FDA-approved products include INGREZZA and Orilissa, with a strong clinical development pipeline.
Jude Onyia sold 59,819 shares of NBIX on 9 July at $130.46 per share, worth a total of $7.8M. They now own 18,289 NBIX shares, or a 77% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.